Cas13

Cas13 is a family of orthologous CRISPR-associated endonucleases that target RNA (unlike Cas9 and Cas12, which target DNA). Cas13 employs a single endonuclease to bind and cleave specific ssRNAs with sequence complementarity to a guide RNA. Cas13 performs two distinct ribonuclease functions: procession of its own CRISPR RNA (crRNA) and catalysis of target RNA cleavage. The system's specificity allows for the correction of mutations at the transcript level.

Cas13 remains bound to the target and then cleaves other ssRNA molecules non-discriminately. This collateral cleavage property is exploited in the development of various diagnostic technologies. It has been used to efficiently repair KRAS-G12D mRNA in pancreatic cancer models while minimizing effects on healthy cells; adapted into tools such as the REPAIR platform, which edits RNA bases to treat genetic disorders, including Usher syndrome, in animal models; and utilized in diagnostic platforms like SHERLOCK to detect pathogens, tumor DNA, and viral variants with high sensitivity. Its PAM-independent targeting and reduced off-target effects make it suitable for RNA imaging, phage genome engineering, and transient gene regulation.